Money Matters Archives | Page 3 of 7

Targeted Therapy for Early-Stage Lung Cancer?

A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.

by Ashley P. Taylor

A Missed Conversation

Despite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.

by Marcus A. Banks

The Return to Work

What happens if your workplace reopens before you're ready to return or you're an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.

by Jen Tota McGivney

Forward Look

Here Come the Biosimilars

As patents expire on biologic drugs, cancer patients get new options.

by Stephen Ornes

Parking Costs Take a Hidden Toll on Cancer Patients

People with cancer can pay significant costs for parking at cancer centers while receiving their treatment, a study finds.

by Marcus A. Banks

Survivor Profile

Sharing Her Strength

Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

by Lindsey Konkel

Using Leftover Cancer Drugs to Help Others

Cancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.

by Jon Kelvey

Forward Look

Getting Help to Avoid Financial Distress

Todd Yezefski on financial navigators.

by Sue Rochman

Despite Generic Imatinib, Cost of Treating CML Remains High

The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.

by Anna Azvolinsky